IDXX logo

IDEXX Laboratories, Inc. (IDXX)

Profile

Full Name

IDEXX Laboratories, Inc.

Ticker

NASDAQ: IDXX

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

June 21, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.idexx.com

Employees

11000

Key Details

Price

$533.37(-1.43%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.90B(+6.46% YoY)

Annual EPS

$10.67(+6.06% YoY)

PE ratio

49.29

Next earnings date

Aug 4, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $533.37
    IDXX price is $533.37

    30-Day Relative Volume

    0.55
    IDXX 30-day relative volume is 0.55

    Price Performance

    Price Most recent change

    -1.43%
    IDXX price was down -1.43% on Jul 11, 2025

    Price YTD change

    +29.01%
    IDXX price is up +29.01% since January 1st

    Price 1-year change

    +9.35%
    IDXX price is up +9.35% year-on-year

    Price 3-year change

    +44.29%
    IDXX price is up +44.29% over the past 3 years

    Price Range

    Price All-time high

    $706.95
    IDXX price is currently -24.55% below its historical high of $706.95

    Price 3-year low

    $317.06
    IDXX price is currently +68.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $42.89B
    IDXX market capitalization is $42.89 billion

    Market cap 3-year change

    +39.09%
    IDXX market capitalization is up +39.09% over the past 3 years

    Market cap All-time high

    $60.04B
    IDXX market capitalization is currently -28.56% below its historical high of $60.04 billion

    Market cap sector rank

    97.02%
    IDXX market capitalization is higher than 97.02% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.49%
    IDXX shares outstanding is down -2.49% year-on-year

    Shares Outstanding 3-Year Change

    -3.6%
    IDXX shares outstanding is down -3.6% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.86
    IDXX beta is 0.86

    200-day SMA

    $455.71
    IDXX price is currently +17.04% above its 200-day simple moving average

    50-day SMA

    $515.88
    IDXX price is currently +3.39% above its 50-day simple moving average

    RSI

    54.95
    IDXX 14-day relative strength index is 54.95

    Volume

    0.55
    IDXX 30-day relative volume is 0.55

    ATR

    $10.51
    IDXX average true range is $10.51

    10-day Historical Volatility

    13.98%
    IDXX 10-day historical volatility is 13.98%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.90B
    IDXX annual revenue is $3.90 billion

    Revenue Analysts estimate

    $4.14B
    IDXX annual revenue is currently -5.79% lower than the consensus analysts' forecast

    Revenue 1-year change

    +6.46%
    IDXX annual revenue is up +6.46% year-on-year

    Revenue Sector rank

    90.26%
    IDXX annual revenue is higher than 90.26% of companies in Healthcare sector

    EPS

    EPS

    $10.67
    IDXX annual earnings per share is $10.67

    EPS Analysts estimate

    $12.18
    IDXX annual earnings per share is currently -12.39% lower than the consensus analysts' forecast

    EPS 1-year change

    +6.06%
    IDXX annual earnings per share is up +6.06% year-on-year

    EPS Sector rank

    98.09%
    IDXX annual earnings per share is higher than 98.09% of companies in Healthcare sector

    Profit

    Gross profit

    $2.38B
    IDXX annual gross profit is $2.38 billion

    Gross margin

    61.04%
    IDXX annual gross profit margin is 61.04%

    Operating profit

    $1.13B
    IDXX annual operating income is $1.13 billion

    Operating margin

    28.95%
    IDXX annual operating profit margin is 28.95%

    Net income

    $887.87M
    IDXX annual net profit is $887.87 million

    Net margin

    22.78%
    IDXX annual net profit margin is 22.78%

    Expenses

    Total expenses

    $2.77B
    IDXX annual total expenses is $2.77 billion

    Operating expenses

    $1.25B
    IDXX annual total operating expenses is $1.25 billion

    Cost of goods sold

    $1.52B
    IDXX annual cost of goods sold is $1.52 billion

    Selling, general & administrative expenses

    $1.03B
    IDXX annual SGA is $1.03 billion

    Depreciation and amortization

    $129.94M
    IDXX annual depreciation & amortization is $129.94 million

    Interest expense

    $31.20M
    IDXX annual interest expense is $31.20 million

    Income tax

    $221.96M
    IDXX annual income tax is $221.96 million

    EBIT & EBITDA

    EBIT

    $1.13B
    IDXX annual earnings before interest & taxes is $1.13 billion

    EBITDA

    $1.13B
    IDXX annual EBITDA is $1.13 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.29B
    IDXX annual total assets is $3.29 billion

    Non current assets

    $1.89B
    IDXX annual long term assets is $1.89 billion

    Current assets

    $1.40B
    IDXX annual total current assets is $1.40 billion

    Cash and cash equivalents

    $288.27M
    IDXX annual cash & cash equivalents is $288.27 million

    Accounts receivable

    $473.57M
    IDXX annual accounts receivable is $473.57 million

    Inventory

    $381.88M
    IDXX annual inventory is $381.88 million

    Liabilities

    Total liabilities

    $1.70B
    IDXX annual total liabilities is $1.70 billion

    Long term liabilities

    $630.21M
    IDXX annual total long term liabilities is $630.21 million

    Current liabilities

    $1.07B
    IDXX annual total current liabilities is $1.07 billion

    Accounts payable

    $114.21M
    IDXX annual accounts payable is $114.21 million

    Debt

    Total debt

    $986.95M
    IDXX annual total debt is $986.95 million

    Total debt 1-year change

    -7.53%
    IDXX annual total debt is down -7.53% year-on-year

    Long term debt

    $547.62M
    IDXX annual long term debt is $547.62 million

    Short term debt

    $439.33M
    IDXX annual short term debt is $439.33 million

    Equity & Capital

    Shareholders equity

    $1.60B
    IDXX annual stockholders equity is $1.60 billion

    Book value

    $1.60B
    IDXX annual book value is $1.60 billion

    Retained earnings

    $5.33B
    IDXX annual retained earnings is $5.33 billion

    Working capital

    $331.98M
    IDXX annual working capital is $331.98 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $929.00M
    IDXX annual cash flow from operations is $929.00 million

    Cash from operations 1-year change

    +2.48%
    IDXX annual cash flow from operations is up +2.48% year-on-year

    Cash from investing

    -$207.06M
    IDXX annual cash flow from investing activities is -$207.06 million

    Cash from investing 1-year change

    -65.31%
    IDXX annual cash flow from investing activities is down -65.31% year-on-year

    Cash from financing

    -$878.07M
    IDXX annual cash flow from financing activities is -$878.07 million

    Cash from financing 1-year change

    -98.66%
    IDXX annual cash flow from financing activities is down -98.66% year-on-year

    CAPEX

    CAPEX

    $120.92M
    IDXX annual capital expenditures is $120.92 million

    CAPEX 1-year change

    -9.51%
    IDXX annual capital expenditures is down -9.51% year-on-year

    Free Cash Flow

    Free cash flow

    $808.08M
    IDXX annual free cash flow is $808.08 million

    Free cash flow 1-year change

    +4.55%
    IDXX annual free cash flow is up +4.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    61.04%
    IDXX annual gross profit margin is 61.04%

    Operating margin

    28.95%
    IDXX annual operating profit margin is 28.95%

    Net margin

    22.78%
    IDXX annual net profit margin is 22.78%

    ROA & ROE

    ROA

    27.10%
    IDXX annual return on assets is 27.10%

    ROE

    57.66%
    IDXX annual return on equity is 57.66%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    49.29
    IDXX price to earnings ratio is 49.29

    PE ratio Sector rank

    78.87%
    IDXX price to earnings ratio is higher than 78.87% of companies in Healthcare sector

    PB Ratio

    PB ratio

    29.62
    IDXX price to book ratio is 29.62

    PB ratio Sector rank

    97.02%
    IDXX price to book ratio is higher than 97.02% of companies in Healthcare sector

    PS Ratio

    PS ratio

    10.91
    IDXX price to sales ratio is 10.91

    PS ratio Sector rank

    78.55%
    IDXX price to sales ratio is higher than 78.55% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $43.79B
    IDXX enterprise value is $43.79 billion

    Enterprise value Sector rank

    97.17%
    IDXX enterprise value is higher than 97.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    33.96
    IDXX EV/EBITDA is 33.96

    EV/EBITDA Sector rank

    95.07%
    IDXX EV/EBITDA is higher than 95.07% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.31
    IDXX annual current ratio is 1.31

    Quick ratio

    0.95
    IDXX annual quick ratio is 0.95

    Leverage

    Debt to equity

    0.54
    IDXX annual debt to equity ratio is 0.54

    Interest coverage ratio

    36.16
    IDXX annual interest coverage ratio is 36.16

    Risk & Stability

    Piotroski F-Score

    7
    IDXX piotroski f-score is 7

    Altman Z-Score

    19.86
    IDXX altman z-score is 19.86

    Analyst ratings

    Recent major analysts updates

    Jul 2, 25 Stifel
    Hold
    Jun 11, 25 Leerink Partners
    Outperform
    May 19, 25 Stifel
    Hold
    May 5, 25 Morgan Stanley
    Overweight
    Apr 21, 25 B of A Securities
    Neutral
    Apr 15, 25 Morgan Stanley
    Overweight
    Apr 14, 25 Stifel
    Hold
    Feb 10, 25 Piper Sandler
    Neutral
    Feb 4, 25 Morgan Stanley
    Overweight
    Feb 4, 25 Barclays
    Overweight

    Institutional Ownership

    Screeners with IDXX included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    NASDAQ 100 companies
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    S&P 500 companies
    • What is the ticker symbol for IDEXX Laboratories, Inc.?
    • Does IDEXX Laboratories, Inc. pay dividends?
    • What sector is IDEXX Laboratories, Inc. in?
    • What industry is IDEXX Laboratories, Inc. in?
    • What country is IDEXX Laboratories, Inc. based in?
    • When did IDEXX Laboratories, Inc. go public?
    • Is IDEXX Laboratories, Inc. in the S&P 500?
    • Is IDEXX Laboratories, Inc. in the NASDAQ 100?
    • Is IDEXX Laboratories, Inc. in the Dow Jones?
    • When was IDEXX Laboratories, Inc.'s last earnings report?
    • When does IDEXX Laboratories, Inc. report earnings?

    What is the ticker symbol for IDEXX Laboratories, Inc.?

    The ticker symbol for IDEXX Laboratories, Inc. is NASDAQ:IDXX

    Does IDEXX Laboratories, Inc. pay dividends?

    No, IDEXX Laboratories, Inc. does not pay dividends

    What sector is IDEXX Laboratories, Inc. in?

    IDEXX Laboratories, Inc. is in the Healthcare sector

    What industry is IDEXX Laboratories, Inc. in?

    IDEXX Laboratories, Inc. is in the Diagnostics & Research industry

    What country is IDEXX Laboratories, Inc. based in?

    IDEXX Laboratories, Inc. is headquartered in United States

    When did IDEXX Laboratories, Inc. go public?

    IDEXX Laboratories, Inc.'s initial public offering (IPO) was on June 21, 1991

    Is IDEXX Laboratories, Inc. in the S&P 500?

    Yes, IDEXX Laboratories, Inc. is included in the S&P 500 index

    Is IDEXX Laboratories, Inc. in the NASDAQ 100?

    Yes, IDEXX Laboratories, Inc. is included in the NASDAQ 100 index

    Is IDEXX Laboratories, Inc. in the Dow Jones?

    No, IDEXX Laboratories, Inc. is not included in the Dow Jones index

    When was IDEXX Laboratories, Inc.'s last earnings report?

    IDEXX Laboratories, Inc.'s most recent earnings report was on May 1, 2025

    When does IDEXX Laboratories, Inc. report earnings?

    The next expected earnings date for IDEXX Laboratories, Inc. is August 4, 2025
    On this page